Pharmabiz5h
Healthark reveals game-changing trends in India’s life sciences & healthcare GCC sector
Healthark reveals game-changing trends in India’s life sciences & healthcare GCC sector: Our Bureau, Mumbai Wednesday, ...
Pharmabiz11h
KPRDO calls on state govt to allocate funds for welfare of pharmacists in state Budget 2025-26
Nandita Vijayasimha, Bengaluru Wednesday, February 26, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Two-phase study leads to Monteloeder’s newest nootropic for cognitive performance
Two-phase study leads to Monteloeder’s newest nootropic for cognitive performance: Madrid Wednesday, February 26, 2025, 18:00 Hrs [IST] A new study illustrates the research jour ...
Pharmabiz2h
Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients
Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients: Indianapolis Wednesday, February 26, 2025, 17:00 Hrs [IST] Eli Lilly and Company announ ...
Pharmabiz4h
Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle
Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle: Greenfield, Indiana Wednesday, February 26, 2025, 15:0 ...
Pharmabiz4h
C-CAMP and PariSanté Campus to establish an Indo French Life Sciences Sister Innovation Hub
C-CAMP and PariSanté Campus to establish an Indo French Life Sciences Sister Innovation Hub: Our Bureau, Bengaluru Wednesday, February 26, 2025, 14:30 Hrs [IST] Centre for Cellul ...
Pharmabiz6h
YolTech Therapeutics reports positive clinical data for YOLT-203, an in vivo gene editing therapy for primary hyperoxaluria type 1
YolTech Therapeutics reports positive clinical data for YOLT-203, an in vivo gene editing therapy for primary hyperoxaluria type 1: Shanghai, China Wednesday, February 26, 2025, 1 ...
Pharmabiz7h
Telangana life sciences sector gets a major boost at Bio Asia 2025
Telangana life sciences sector gets a major boost at Bio Asia 2025: Our Bureau, Mumbai Wednesday, February 26, 2025, 11:30 Hrs [IST] The 22nd edition of BioAsia 2025, Asia’s lar ...
Pharmabiz7h
EY-Parthenon & Microsoft unveil pharma AI adoption framework at BioAsia 2025
EY-Parthenon & Microsoft unveil pharma AI adoption framework at BioAsia 2025: Our Bureau, Mumbai Wednesday, February 26, 2025, 12:10 Hrs [IST] EY-Parthenon and Microsoft have laun ...
Pharmabiz11h
IPEC Federation makes available QbD Version 2, 2025
The International Pharmaceutical Excipients Council Federation, (IPEC Federation) has now announced the availability of the revised IPEC Incorporation of Pharmaceutical Excipients into Product ...
Pharmabiz9h
US FDA approves Mirum’s Ctexli tablets to treat cerebrotendinous xanthomatosis
US Food and Drug Administration (FDA) has approved Ctexli (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous xanthomatosis (CTX). Ctexli is the first and only ...
Pharmabiz10h
Japanese MHLW approves Sarclisa for patients with newly diagnosed multiple myeloma
Japanese MHLW approves Sarclisa for patients with newly diagnosed multiple myeloma: Paris Wednesday, February 26, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour and Welfare ...